Under construction – not a live service

Skip to content

Frontlight Research

Trial site

ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO

Cagliari, ItalyNot linked to an institution yet

1running trials
4closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
NCT03190525· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia
NCT03367299· Phase 2· Source
Completed
Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia
NCT02388048· Phase 2· Source
Completed
Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leukemia
NCT02232386· Phase 2· Source
Completed
Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
NCT01699217· Source

Site data: ClinicalTrials.govUpdated 3 Nov 2026

Report an error

Under construction, not live – ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO: trial site – Frontlight Research